Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

93 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Differences in HIV natural history among African and non-African seroconverters in Europe and seroconverters in sub-Saharan Africa.
Pantazis N, Morrison C, Amornkul PN, Lewden C, Salata RA, Minga A, Chipato T, Jaffe H, Lakhi S, Karita E, Porter K, Meyer L, Touloumi G; CASCADE Collaboration in EuroCoord and ANRS 1220 Primo-CI Study Group. Pantazis N, et al. Among authors: minga a. PLoS One. 2012;7(3):e32369. doi: 10.1371/journal.pone.0032369. Epub 2012 Mar 6. PLoS One. 2012. PMID: 22412867 Free PMC article.
Effects of the COVID-19 Pandemic on ART Initiation and Access to HIV Viral Load Monitoring in Adults Living With HIV in West Africa: A Regression Discontinuity Analysis.
Ben Farhat J, Tiendrebeogo T, Malateste K, Poda A, Minga A, Messou E, Chenal H, Ezechi O, Ofotokun I, Ekouevi DK, Bonnet F, Barger D, Jaquet A; IeDEA West Africa Collaboration. Ben Farhat J, et al. Among authors: minga a. J Acquir Immune Defic Syndr. 2024 Jun 1;96(2):114-120. doi: 10.1097/QAI.0000000000003404. J Acquir Immune Defic Syndr. 2024. PMID: 38427928
Sex-Based Disparities in the Transition to Dolutegravir-Based Antiretroviral Therapy in West African HIV Cohorts.
Tiendrebeogo T, Malateste K, Poda A, Minga A, Messou E, Chenal H, Ezechi O, Ekouevi DK, Ofotokun I, Jaquet A; IeDEA West Africa Collaboration. Tiendrebeogo T, et al. Among authors: minga a. Open Forum Infect Dis. 2024 Mar 19;11(5):ofae139. doi: 10.1093/ofid/ofae139. eCollection 2024 May. Open Forum Infect Dis. 2024. PMID: 38680609 Free PMC article.
Field evaluation of an improved assay using a heat-dissociated p24 antigen for adults mainly infected with HIV-1 CRF02_AG strains in Côte d'Ivoire, West Africa.
Bonard D, Rouet F, Toni TA, Minga A, Huet C, Ekouévi DK, Dabis F, Salamon R, Rouzioux C; ANRS 1220 PRIMO-CI Study Group. Bonard D, et al. Among authors: minga a. J Acquir Immune Defic Syndr. 2003 Nov 1;34(3):267-73. doi: 10.1097/00126334-200311010-00002. J Acquir Immune Defic Syndr. 2003. PMID: 14600570 Clinical Trial.
CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial): a randomised trial.
Danel C, Moh R, Minga A, Anzian A, Ba-Gomis O, Kanga C, Nzunetu G, Gabillard D, Rouet F, Sorho S, Chaix ML, Eholié S, Menan H, Sauvageot D, Bissagnene E, Salamon R, Anglaret X; Trivacan ANRS 1269 trial group. Danel C, et al. Among authors: minga a. Lancet. 2006 Jun 17;367(9527):1981-9. doi: 10.1016/S0140-6736(06)68887-9. Lancet. 2006. PMID: 16782488 Clinical Trial.
93 results